Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation

Clinical trial NCT01700751 · COMPLETED

Trial details

NCT number: NCT01700751
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Acute Myeloid Leukemia, Lymphoblastic,Acute Myelodysplastic Syndromes

Start date: 2013-02-25
Primary completion: 2015-11-11
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.